Also listed on Roche Products Limited, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Mar 24, 2034 · Low confidence
20-year base term ends Mar 24, 2034
Mar 24, 2014
Mar 24, 2034
Jan 10, 2023
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 2 maintenance fees is paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 24, 2014, when application PCT/EP2014/055790, the earliest non-provisional in its chain, was filed (this one was filed Jun 3, 2020); a parent in its chain could not be resolved (the next row) | Mar 24, 2034 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,584,385, US 10,711,303, US 11,401,554, US 9,909,178) | resolves to Mar 24, 2034, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 15877019, 15877019 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Mar 24, 2034 | Low confidence |
This family
| US 9,909,178 | In force Mar 2034 | Mar 2034 |
| Application 15/877,019 | Abandoned not computed | not computed |
| US 10,711,303 | In force Mar 2034 | Mar 2034 |
| US 11,549,142 | this patent Mar 2034 | Mar 2034 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 24, 2020 Reel 53029, frame 310 | Niesor, Eric J. | F. Hoffmann-La Roche AG | Assignment of Assignor's Interest |
| Jun 24, 2020 Reel 53029, frame 739 | Tardif, Jean-claude; Dube, Marie-pierre | Montreal Heart Institute | Assignment of Assignor's Interest |
| Jun 24, 2020 Reel 53030, frame 121 | Upmanyu, Ruchi | Roche Products Limited | Assignment of Assignor's Interest |
| Jun 24, 2020 Reel 53030, frame 327 | Roche Products Limited | F. Hoffmann-La Roche AG | Assignment of Assignor's Interest |
| Jun 24, 2020 Reel 53030, frame 393 | Montreal Heart Institute | F. Hoffmann-La Roche AG | Assignment of Assignor's Interest |
| Jun 24, 2020 Reel 53030, frame 618 | F. Hoffmann-La Roche AG | Hoffmann-La Roche Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,584,385, US 10,711,303, US 11,401,554, US 9,909,178, ends no earlier than this term, so it caps nothing.